Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-09-22

Clinical Trial Update: Adipose Stromal Cells Injection in the Myocardium for Induction of Revascularization [Phase 3]

View source ↗

Summary

Phase 3 trial of adipose stromal cell injection in the myocardium for revascularization was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adipose stromal cells injection in the myocardium

Snippet

Sponsor: Hospital do Coracao | Conditions: Ischemic Heart Disease, Myocardial Ischemia | Phase 3 | Status: WITHDRAWN